to be equivalent to nanosonics GSS should range from $700-800m market cap currently. my reasoning is it should be valued in line with that NAN type of product - machine + cartridge albeit with greater cover use due to cartridge / consumables being compatible with majority high throughput PCR machines
when Covid becomes the new normal I can imagine 'panel' respiratory PCR eg those that are able to test multiple influenzas and Covid in one test should become standard. influenza is still a reportable disease and the Covid reporting will be mandatory /managed pursuant to the surveillance for the foreseeable future at least in line with that scheme
the market share of enteric panel will catapult this small cap to the ASX 200/300
- Forums
- ASX - By Stock
- GSS
- News: GSS Genetic Signatures Expects Sales Of At Least A$21M For Half Year
News: GSS Genetic Signatures Expects Sales Of At Least A$21M For Half Year, page-19
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
Add GSS (ASX) to my watchlist
(20min delay)
|
|||||
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $181.2M |
Open | High | Low | Value | Volume |
79.0¢ | 80.0¢ | 77.0¢ | $307.5K | 390.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 296 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.780 |
1 | 12500 | 0.750 |
1 | 1000 | 0.740 |
3 | 16361 | 0.735 |
3 | 102069 | 0.730 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 296 | 1 |
0.820 | 8456 | 3 |
0.845 | 1184 | 1 |
0.850 | 23008 | 1 |
0.860 | 12935 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |